GLP-1 discovery may offer better appetite suppression than Ozempic
|

GLP-1 discovery may offer better appetite suppression than Ozempic

Ozempic maker Novo Nordisk says it has developed a compound that’s shown to be a one-two punch for appetite suppression and weight loss in mice. Ozempic promotes weight loss by mimicking the GLP-1 hormone the body naturally produces after eating, so users feel fuller for longer. This new potential therapy…

9 ways to reduce the risk of early-onset cancer: experts
|

9 ways to reduce the risk of early-onset cancer: experts

Cancer may seem like an old person’s disease, but studies have shown that certain types have become increasingly prevalent in Americans younger than 50. Recent research found that Gen X and millennial Americans are at higher risk of developing 17 cancers compared to older generations. Rates of colon cancer diagnoses, for example, have…